The Federal Circuit recently held certain method of treatment claims patent eligible under step one of Alice, reversing a district court’s judgment on the pleadings. In that same case, the Federal Circuit upheld the district court’s obviousness and obviousness-type double patenting determinations invalidating the claims of two other patents because the claimed treatments fell within a prior art dosage range.